questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Porphyrines : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Porphyrines : Questions médicales les plus fréquentes",
"headline": "Porphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Porphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Porphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pigments biologiques",
"url": "https://questionsmedicales.fr/mesh/D010860",
"about": {
"@type": "MedicalCondition",
"name": "Pigments biologiques",
"code": {
"@type": "MedicalCode",
"code": "D010860",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Coproporphyrines",
"alternateName": "Coproporphyrins",
"url": "https://questionsmedicales.fr/mesh/D003306",
"about": {
"@type": "MedicalCondition",
"name": "Coproporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D003306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Deutéroporphyrines",
"alternateName": "Deuteroporphyrins",
"url": "https://questionsmedicales.fr/mesh/D003905",
"about": {
"@type": "MedicalCondition",
"name": "Deutéroporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D003905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Étioporphyrines",
"alternateName": "Etioporphyrins",
"url": "https://questionsmedicales.fr/mesh/D005044",
"about": {
"@type": "MedicalCondition",
"name": "Étioporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D005044",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.340"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrines",
"alternateName": "Hematoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D006415",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D006415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrine D",
"alternateName": "Hematoporphyrin Derivative",
"url": "https://questionsmedicales.fr/mesh/D017324",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrine D",
"code": {
"@type": "MedicalCode",
"code": "D017324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mésoporphyrines",
"alternateName": "Mesoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D008652",
"about": {
"@type": "MedicalCondition",
"name": "Mésoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D008652",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.620"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métalloporphyrines",
"alternateName": "Metalloporphyrins",
"url": "https://questionsmedicales.fr/mesh/D008665",
"about": {
"@type": "MedicalCondition",
"name": "Métalloporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D008665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hème",
"alternateName": "Heme",
"url": "https://questionsmedicales.fr/mesh/D006418",
"about": {
"@type": "MedicalCondition",
"name": "Hème",
"code": {
"@type": "MedicalCode",
"code": "D006418",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hémine",
"alternateName": "Hemin",
"url": "https://questionsmedicales.fr/mesh/D006427",
"about": {
"@type": "MedicalCondition",
"name": "Hémine",
"code": {
"@type": "MedicalCode",
"code": "D006427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587.462"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hémine",
"alternateName": "Hemin",
"url": "https://questionsmedicales.fr/mesh/D006427",
"about": {
"@type": "MedicalCondition",
"name": "Hémine",
"code": {
"@type": "MedicalCode",
"code": "D006427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.640.587.462"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protoporphyrines",
"alternateName": "Protoporphyrins",
"url": "https://questionsmedicales.fr/mesh/D011524",
"about": {
"@type": "MedicalCondition",
"name": "Protoporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uroporphyrines",
"alternateName": "Uroporphyrins",
"url": "https://questionsmedicales.fr/mesh/D014578",
"about": {
"@type": "MedicalCondition",
"name": "Uroporphyrines",
"code": {
"@type": "MedicalCode",
"code": "D014578",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.880"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"alternateName": "Porphyrins",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Harry L Anderson",
"url": "https://questionsmedicales.fr/author/Harry%20L%20Anderson",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Oxford, Chemistry Research Laboratory, OX1 3TA, Oxford, UK."
}
},
{
"@type": "Person",
"name": "Donato Monti",
"url": "https://questionsmedicales.fr/author/Donato%20Monti",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Sapienza, University of Rome Piazzale Aldo Moro 5 00185 Rome Italy."
}
},
{
"@type": "Person",
"name": "Manuela Stefanelli",
"url": "https://questionsmedicales.fr/author/Manuela%20Stefanelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
},
{
"@type": "Person",
"name": "Gabriele Magna",
"url": "https://questionsmedicales.fr/author/Gabriele%20Magna",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
},
{
"@type": "Person",
"name": "Roberto Paolesse",
"url": "https://questionsmedicales.fr/author/Roberto%20Paolesse",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Science and Technologies, University of Rome Tor Vergata via della Ricerca Scientifica 1 00133 Rome Italy gabriele.magna@uniroma2.it."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cognitive dysfunction and the 25-item National Eye Institute Visual Function Questionnaire.",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36407937",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/dad2.12378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of visual imagery in COVID-19 social media posts on users' perception.",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36426258",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7717/peerj-cs.1153"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bibliometric and visual analysis in the field of ketogenic diet on cancer from 2012 to 2021.",
"datePublished": "2022-11-10",
"url": "https://questionsmedicales.fr/article/36438725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnut.2022.1060436"
}
},
{
"@type": "ScholarlyArticle",
"name": "Element-specific visualization of dynamic magnetic coupling in a Co/Py bilayer microstructure.",
"datePublished": "2022-11-04",
"url": "https://questionsmedicales.fr/article/36333578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-23273-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visual Exploration of Machine Learning Model Behavior with Hierarchical Surrogate Rule Sets.",
"datePublished": "2022-11-03",
"url": "https://questionsmedicales.fr/article/36327192",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/TVCG.2022.3219232"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Porphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Porphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Porphyrines",
"description": "Comment diagnostiquer une porphyrie ?\nQuels tests sont utilisés pour les porphyrines ?\nQuels symptômes indiquent une porphyrie ?\nLes tests génétiques sont-ils nécessaires ?\nComment interpréter les résultats des tests ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Porphyrines",
"description": "Quels sont les symptômes courants des porphyries ?\nLes porphyries causent-elles des douleurs ?\nY a-t-il des symptômes cutanés ?\nLes porphyries affectent-elles le système nerveux ?\nLes symptômes varient-ils selon le type de porphyrie ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Porphyrines",
"description": "Comment prévenir les crises de porphyrie ?\nY a-t-il des conseils diététiques pour les patients ?\nLes patients doivent-ils éviter certains médicaments ?\nLa gestion du stress est-elle importante ?\nLes patients doivent-ils être suivis régulièrement ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Porphyrines",
"description": "Quel est le traitement principal des porphyries ?\nLes transfusions sanguines sont-elles nécessaires ?\nY a-t-il des médicaments spécifiques pour les porphyries ?\nComment gérer les crises de porphyrie ?\nLa photoprotection est-elle recommandée ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Porphyrines",
"description": "Quelles sont les complications possibles des porphyries ?\nLes porphyries peuvent-elles causer des dommages au foie ?\nY a-t-il un risque accru de cancer ?\nLes complications neurologiques sont-elles fréquentes ?\nComment gérer les complications des porphyries ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Porphyrines",
"description": "Quels sont les facteurs de risque des porphyries ?\nL'hérédité joue-t-elle un rôle ?\nLes femmes sont-elles plus à risque ?\nL'alcool augmente-t-il le risque ?\nLes infections peuvent-elles aggraver la condition ?",
"url": "https://questionsmedicales.fr/mesh/D011166?mesh_terms=Primary+Visual+Cortex&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une porphyrie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins et urinaires pour mesurer les niveaux de porphyrines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les porphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'analyse des urines, du sang et parfois des biopsies de peau."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une porphyrie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des douleurs abdominales, des troubles neurologiques et des photosensibilités."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent aider à confirmer certains types de porphyries héréditaires."
}
},
{
"@type": "Question",
"name": "Comment interpréter les résultats des tests ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux élevés de porphyrines dans le sang ou l'urine indiquent une porphyrie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des porphyries ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des éruptions cutanées et des troubles mentaux."
}
},
{
"@type": "Question",
"name": "Les porphyries causent-elles des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales aiguës sont fréquentes lors des crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des éruptions cutanées et une photosensibilité peuvent survenir, surtout dans la porphyrie cutanée."
}
},
{
"@type": "Question",
"name": "Les porphyries affectent-elles le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent provoquer des troubles neurologiques, y compris des crises et des hallucinations."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de porphyrie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de porphyrie présente des symptômes spécifiques et des manifestations cliniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crises de porphyrie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs comme certains médicaments, l'alcool et le stress peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conseils diététiques pour les patients ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et riche en glucides peut aider à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains médicaments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent déclencher des crises et doivent être évités."
}
},
{
"@type": "Question",
"name": "La gestion du stress est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress est cruciale pour prévenir les crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils être suivis régulièrement ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical régulier est essentiel pour surveiller l'évolution de la maladie."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des porphyries ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal inclut l'évitement des déclencheurs et des médicaments pour soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des transfusions peuvent être nécessaires pour traiter l'anémie associée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour les porphyries ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme l'hématine peuvent être utilisés pour traiter les crises aiguës de porphyrie."
}
},
{
"@type": "Question",
"name": "Comment gérer les crises de porphyrie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les crises peuvent être gérées par des soins d'urgence et des traitements symptomatiques."
}
},
{
"@type": "Question",
"name": "La photoprotection est-elle recommandée ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients doivent éviter l'exposition au soleil et utiliser des écrans solaires."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des porphyries ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions nerveuses, des problèmes hépatiques et des infections."
}
},
{
"@type": "Question",
"name": "Les porphyries peuvent-elles causer des dommages au foie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines porphyries peuvent entraîner des lésions hépatiques graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines porphyries, comme la porphyrie cutanée, peuvent augmenter le risque de cancer de la peau."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques peuvent survenir, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des porphyries ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des porphyries ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, certains médicaments et des conditions hépatiques."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines porphyries sont héréditaires et peuvent être transmises dans les familles."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent que les femmes peuvent être plus touchées par certaines porphyries."
}
},
{
"@type": "Question",
"name": "L'alcool augmente-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consommation d'alcool peut déclencher des crises chez les personnes prédisposées."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver la condition ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes des porphyries."
}
}
]
}
]
}
Visual function and cognitive impairment are interrelated; however, little is known about the impact of modifying treatable vision impairment on the development of cognitive dysfunction. This study ex...
Participants completed the NEI VFQ 25-Item questionnaire as well as the Mini-Mental State Examination (MMSE). Additionally, all participants were assigned a consensus clinical diagnosis based on estab...
A significant association between overall composite score on the NEI VFQ and total MMSE score was revealed (...
Reduced visual function should raise concerns about cognitive decline and prompt additional assessment....
People receive a wide variety of news from social media. They especially look for information on social media in times of crisis with the desire to assess the risk they face. This risk assessment, and...
Increasing evidence demonstrated that the ketogenic diet (KD) played a positive effect on cancer treatment. However, no systematic review and bibliometric analysis were conducted in this field. This s...
We present the element-specific and time resolved visualization of uniform ferromagnetic resonance excitations of a Permalloy (Py) disk-Cobalt (Co) stripe bilayer microstructure. The transverse high f...
One of the potential solutions for model interpretation is to train a surrogate model: a more transparent model that approximates the behavior of the model to be explained. Typically, classification r...
Ebola virus (EBOV) causes severe EBOV disease (EVD) in humans and non-human primates. Currently, limited countermeasures are available, and the virus must be studied in biosafety level-4 (BSL-4) labor...
Proper body balance is maintained by both sensory, i.e., vision, hearing, vestibular, and proprioception, and motor nervous systems. Visual control facilitates balance both in a static position, as we...
The study comprised a group of 30 individuals visually impaired from birth aged 18-24 years. The control group consisted of 50 persons in the same age range as the study group. The trial was performed...
No statistically significant differences were found in the posturography test on the stable platform between the study groups. When tested on an unstable ground surface, the visually impaired subjects...
Visually impaired individuals present a poorer ability to maintain balance under dynamic conditions. Tests conducted on the unstable surface platform seem to be more relevant and applicable in the dia...
Since the global epidemic of the coronavirus disease 2019 (COVID-19), a large number of immunological studies related to COVID-19 have been published in various immunology journals. However, the resul...
Publications on COVID-19 in major immunology journals were obtained from the Web of Science Core Collection. CiteSpace, VOSviewer, and R-bibliometrix were comprehensively used for bibliometric and vis...
1,331 and 5,000 publications of 10 journals with high impact factors and 10 journals with the most papers were included, respectively. The USA, China, England, and Italy made the most significant cont...
This study systematically uncovered a holistic picture of the current research on COVID-19 published in major immunology journals from the perspective of bibliometrics, which will provide a reference ...
To identify factors associated with visual acuity regression following successful treatment of anisometropic amblyopia....
This was a retrospective cohort study. Database records for 100 and 61 children with anisometropic amblyopia who met at least one criterion for successful treatment proposed by the Pediatric Eye Disea...
Sixty-eight (42.5%) children regressed within 1 year of successful treatment. Among the 27 predictor variables considered within the statistical modeling process, the three most important for predicti...
Patients who received treatment at a younger age and responded well to treatment had a lower risk of treatment regression. This pattern of results suggests that early detection of amblyopia and strate...
Thrombomodulin (TM) functions as a dual modulator-anticoagulant and antifibrinolytic potential-by the thrombin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI)....
To analyze the effects of domain-deletion variants of TM on coagulation and fibrinolysis at different concentrations....
Domain-deletion variants of TM, such as D123 (all extracellular regions), E3456 (minimum domains for thrombin-dependent activation of protein C and TAFI), and E456 (minimum domains for that of protein...
A low concentration of either D123 or E3456, but not of E456, prolonged clot lysis time, and delayed the accumulation of fluorescence-labeled plasminogen at the activated platelets/dense fibrin area d...